main content start

MedEnrich | Página principal

Continue Watching

últimos vidéos

últimos vidéos

Brightcove Home Latest Listing

Cáncer de mama

Cáncer de mama

Brightcove Cards Listing

Cáncer de próstata

Brightcove Cards Listing

Mieloma múltiple

Mieloma múltiple

Brightcove Cards Listing

Popular en MedEnrich

Popular in Sin nombre
  • Oncology1m 36s

    Enhancing Global Access to Cancer Medicines

    Over the last decade we have seen emergence of increasing novel therapies like targeted therapy and immunotherapy & this has changed the natural history of disease for patients living with cancer including those with advanced disease.
    biosimilars access generics
  • Myelodysplastic Syndromes3m 14s

    Low Risk MDS - Key Practice Points

    Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasms show considerable heterogeneity with respect to presence of anemia , cytopenia & molecular features.
    ipss -m low risk molecular features
  • Cáncer de mama3m 36s

    Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

    Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
    tumor-infiltrating lymphocytes (tils) promising biomarker
  • "NA"11m 43s

    Sequencing of treatment for Her2 positive MBC in 2022

    Noteworthy treatment options added in the treatment guidelines for Her2 positive MBC are Trastuzumab Deruxtecan (TDXd) and combination of Trastuzumab + Capecitabine +Tucatinib.
    brain metastases her2 positive mbc trastuzumab deruxtecan tucatinib
  • Multiple-Myeloma0m 53s

    Importance of identifying High Risk Patients in Multiple Myeloma

    High risk disease is observed in 30% of Myeloma Cases. Identification of high-risk patients is important as proportion of high-risk cases increase with relapses and can lead to significant mortality.
    high risk myeloma
  • Mieloma múltiple4m 12s

    Key Practice Points -Myeloma Related Renal Impairment

    In patients with renal impairment primary goal is improvement of Renal Function which is associated with improved treatment outcomes. 50% of patients present renal impairment and renal impairment is severe in 15% of patients.
    myeloma renal impairment key practice points
  • Myelodysplastic Syndromes31m 24s

    Improving Diagnosis of MDS -Innovative Solutions

    Modern Web -Based digital tools based on 10 routinely used clinical parameters and Gradient Based Model can help in non-invasive diagnosis of MDS.
    mds diagnosis web based diagnosis her2negative mbc
  • Mieloma múltiple10m 40s

    Recommendations -Management of Myeloma Related Renal Impairment

    Supportive Care, Mechanical Approach and Systemic Antimyeloma treatment are 3 pillars of management of Myeloma related renal impairment. In supportive care prompt initiation of high fluid administration, appropriate use of Bisphosphonates can help.
    myeloma renal impairment lancet guidelines
  • Cáncer de mama29m 30s

    SABCS Update 2022

    Summary of Key Abstracts from SABCS 2022
    recurrence score tailor-x destiny breast 03 adjuvant cdk4/6 inhibitor antibody drug conjugates
  • Cáncer de mama8m 46s

    Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer

    Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC).
    anti-her2 directed therapy her2-positive metastatic breast cancer expert perspective algorithm for management of her2 positive mbc
  • Seminarios web anteriores

    Seminarios web anteriores

    Webinar Cards Listing

    Artículos

    Artículos

    Medbytes Cards Listing
    Hi, can I help?
    Chat de ayudaX
    Equipo de soporte
    ¡Hola! ¿Cómo puedo ayudarlo/a hoy?
    Por favor seleccione alguna de las siguientes opciones.

    Buscar información

    Problemas con el inicio de sesión o registro

    Compartir un comentario